Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2008-01-17
2010-11-23
Whiteman, Brian (Department: 1635)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
Reexamination Certificate
active
07838506
ABSTRACT:
The present research is directed to the identification of non-peptidic inhibitors of cathepsin G characterised by high levels of selectivity and which can be efficaciously used in the treatment and prophylaxis of inflammatory occurrences and procoagulant conditions. The cathepsin G-inhibiting aptamers according to the invention consist of linear DNA or polynucleotide sequences having a chain length of at least 60 nucleotides and being substantially not subjected to undergo efficient base pairing.
REFERENCES:
patent: 5780449 (1998-07-01), Bracht et al.
patent: 6316190 (2001-11-01), Rein et al.
patent: 6399302 (2002-06-01), Lannigan et al.
patent: 7501400 (2009-03-01), Tachas
patent: 0775745 (1997-05-01), None
patent: 0775745 (1999-10-01), None
patent: 9119813 (1991-12-01), None
patent: 9214843 (1992-09-01), None
Vianini et al., “In vitro selection of DNA aptamers that bind L-tyrosinamide,” Bioorganic & Medicinal chemistry, Oct. 2001, pp. 2543-2548, vol. 9, No. 10, Padova, Italy.
Bracht et al., “Isolation and functional characterization of a specific cathepsin G inhibitory aptamer from a pool of synthetic oligonucleotides,” 1996, p. R13, Naunyn-Schmiedeberg's Archives of Pharmacoloty, vol. 353, No. 4.
Ferro Laura Iris
Gatto Barbara
Palumbo Manlio
Pescador Rodolfo
Porta Roberto
Fredrikson & Byron , P.A.
Gentium SpA
Whiteman Brian
LandOfFree
DNA-based aptamers for human cathepsin G does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with DNA-based aptamers for human cathepsin G, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DNA-based aptamers for human cathepsin G will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4236770